Skip to main content
logo
Appili Therapeutics Inc. (TSX:APLI)
Canada flag Canada · Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
At close: Feb 24, 2026

Appili Therapeutics Income Statement

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
0.210.10.830.331.39-
Revenue Growth (YoY)
65.38%-87.86%147.59%-75.97%--
Gross Profit
0.210.10.830.331.39-
Selling, General & Admin
2.482.863.264.625.325.44
Research & Development
3.97.325.623.6220.7410.22
Operating Expenses
6.3810.198.888.2526.0715.66
Operating Income
-6.17-10.09-8.05-7.91-24.68-15.66
Interest Expense
-1.32-2.95-1.63-0.95-1.55-0.12
Interest & Investment Income
-00.020.030.030.12
Currency Exchange Gain (Loss)
0.51-0.330.07-0.360.06-
Other Non Operating Income (Expenses)
4.110.765.890.141.061.34
EBT Excluding Unusual Items
-2.87-2.61-3.71-9.06-25.08-14.33
Other Unusual Items
----0.14--
Pretax Income
-2.87-2.61-3.71-9.21-25.08-14.33
Income Tax Expense
0.090.020.070.040.04-
Net Income
-2.96-2.62-3.78-9.24-25.12-14.33
Net Income to Common
-2.96-2.62-3.78-9.24-25.12-14.33
Shares Outstanding (Basic)
1271211211146759
Shares Outstanding (Diluted)
1271211211146759
Shares Change (YoY)
4.39%-6.63%70.43%12.76%72.40%
EPS (Basic)
-0.02-0.02-0.03-0.08-0.38-0.24
EPS (Diluted)
-0.02-0.02-0.03-0.08-0.38-0.24
Free Cash Flow
-0.010.87-2.49-10.1-19.08-11.46
Free Cash Flow Per Share
-0.01-0.02-0.09-0.29-0.19
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-2990.70%-10040.58%-972.94%-2368.29%-1774.56%-
Profit Margin
-1436.49%-2613.12%-456.96%-2765.90%-1806.18%-
Free Cash Flow Margin
-5.49%862.63%-301.44%-3022.65%-1372.07%-
EBITDA
-6.16-10.07-8.04-7.91-24.67-15.65
D&A For EBITDA
0.010.010.010.010.010.01
EBIT
-6.17-10.09-8.05-7.91-24.68-15.66
Revenue as Reported
0.210.10.840.361.420.12
Source: S&P Global Market Intelligence. Standard template. Financial Sources.